277 related articles for article (PubMed ID: 34867947)
1. Cellular and Molecular Phenotypes of pConsensus Peptide (pCons) Induced CD8
Singh RP; Hahn BH; Bischoff DS
Front Immunol; 2021; 12():718359. PubMed ID: 34867947
[TBL] [Abstract][Full Text] [Related]
2. pConsensus peptide induces tolerogenic CD8+ T cells in lupus-prone (NZB x NZW)F1 mice by differentially regulating Foxp3 and PD1 molecules.
Singh RP; La Cava A; Hahn BH
J Immunol; 2008 Feb; 180(4):2069-80. PubMed ID: 18250412
[TBL] [Abstract][Full Text] [Related]
3. Effects of Peptide-Induced Immune Tolerance on Murine Lupus.
Singh RP; Hahn BH; Bischoff DS
Front Immunol; 2021; 12():662901. PubMed ID: 34093553
[TBL] [Abstract][Full Text] [Related]
4. Blockade of programmed death-1 in young (New Zealand black x New Zealand white)F1 mice promotes the activity of suppressive CD8+ T cells that protect from lupus-like disease.
Wong M; La Cava A; Singh RP; Hahn BH
J Immunol; 2010 Dec; 185(11):6563-71. PubMed ID: 21041733
[TBL] [Abstract][Full Text] [Related]
5. Distinct gene signature revealed in white blood cells, CD4(+) and CD8(+) T cells in (NZBx NZW) F1 lupus mice after tolerization with anti-DNA Ig peptide.
Singh RP; Dinesh R; Elashoff D; de Vos S; Rooney RJ; Patel D; La Cava A; Hahn BH
Genes Immun; 2010 Jun; 11(4):294-309. PubMed ID: 20200542
[TBL] [Abstract][Full Text] [Related]
6. Interferon-inducible gene 202b controls CD8(+) T cell-mediated suppression in anti-DNA Ig peptide-treated (NZB × NZW) F1 lupus mice.
Dinesh R; Hahn BH; La Cava A; Singh RP
Genes Immun; 2011 Jul; 12(5):360-9. PubMed ID: 21326316
[TBL] [Abstract][Full Text] [Related]
7. Differences between CD8+ T cells in lupus-prone (NZB x NZW) F1 mice and healthy (BALB/c x NZW) F1 mice may influence autoimmunity in the lupus model.
Karpouzas GA; La Cava A; Ebling FM; Singh RR; Hahn BH
Eur J Immunol; 2004 Sep; 34(9):2489-99. PubMed ID: 15307181
[TBL] [Abstract][Full Text] [Related]
8. CD4
Peixoto TV; Carrasco S; Botte DAC; Catanozi S; Parra ER; Lima TM; Ugriumov N; Soriano FG; de Mello SBV; Rodrigues CM; Goldenstein-Schainberg C
Adv Rheumatol; 2019 Jul; 59(1):30. PubMed ID: 31340848
[TBL] [Abstract][Full Text] [Related]
9. Major pathogenic steps in human lupus can be effectively suppressed by nucleosomal histone peptide epitope-induced regulatory immunity.
Zhang L; Bertucci AM; Ramsey-Goldman R; Harsha-Strong ER; Burt RK; Datta SK
Clin Immunol; 2013 Dec; 149(3):365-78. PubMed ID: 24211843
[TBL] [Abstract][Full Text] [Related]
10. CD8+ T cell-mediated suppression of autoimmunity in a murine lupus model of peptide-induced immune tolerance depends on Foxp3 expression.
Singh RP; La Cava A; Wong M; Ebling F; Hahn BH
J Immunol; 2007 Jun; 178(12):7649-57. PubMed ID: 17548601
[TBL] [Abstract][Full Text] [Related]
11. The suppression of murine lupus by a tolerogenic peptide involves foxp3-expressing CD8 cells that are required for the optimal induction and function of foxp3-expressing CD4 cells.
Sharabi A; Mozes E
J Immunol; 2008 Sep; 181(5):3243-51. PubMed ID: 18713995
[TBL] [Abstract][Full Text] [Related]
12. Treatment with a consensus peptide based on amino acid sequences in autoantibodies prevents T cell activation by autoantigens and delays disease onset in murine lupus.
Hahn BH; Singh RR; Wong WK; Tsao BP; Bulpitt K; Ebling FM
Arthritis Rheum; 2001 Feb; 44(2):432-41. PubMed ID: 11229475
[TBL] [Abstract][Full Text] [Related]
13. Tolerogenic treatment of lupus mice with consensus peptide induces Foxp3-expressing, apoptosis-resistant, TGFbeta-secreting CD8+ T cell suppressors.
Hahn BH; Singh RP; La Cava A; Ebling FM
J Immunol; 2005 Dec; 175(11):7728-37. PubMed ID: 16301683
[TBL] [Abstract][Full Text] [Related]
14. Tolerance induced by anti-DNA Ig peptide in (NZB×NZW)F1 lupus mice impinges on the resistance of effector T cells to suppression by regulatory T cells.
Yu Y; Liu Y; Shi FD; Zou H; Hahn BH; La Cava A
Clin Immunol; 2012 Mar; 142(3):291-5. PubMed ID: 22137928
[TBL] [Abstract][Full Text] [Related]
15. Very low-dose tolerance with nucleosomal peptides controls lupus and induces potent regulatory T cell subsets.
Kang HK; Michaels MA; Berner BR; Datta SK
J Immunol; 2005 Mar; 174(6):3247-55. PubMed ID: 15749855
[TBL] [Abstract][Full Text] [Related]
16. Modulation of p38 MAPK activity in regulatory T cells after tolerance with anti-DNA Ig peptide in (NZB x NZW)F1 lupus mice.
Lourenço EV; Procaccini C; Ferrera F; Iikuni N; Singh RP; Filaci G; Matarese G; Shi FD; Brahn E; Hahn BH; La Cava A
J Immunol; 2009 Jun; 182(12):7415-21. PubMed ID: 19494264
[TBL] [Abstract][Full Text] [Related]
17. Blockade of programmed death-1 in young (New Zealand Black x New Zealand White)F1 mice promotes the suppressive capacity of CD4+ regulatory T cells protecting from lupus-like disease.
Wong M; La Cava A; Hahn BH
J Immunol; 2013 Jun; 190(11):5402-10. PubMed ID: 23636058
[TBL] [Abstract][Full Text] [Related]
18. Imbalance between CD8
Minning S; Xiaofan Y; Anqi X; Bingjie G; Dinglei S; Mingshun Z; Juan X; Xiaohui J; Huijuan W
Lupus; 2019 Sep; 28(10):1214-1223. PubMed ID: 31399013
[TBL] [Abstract][Full Text] [Related]
19. Regulatory T cell (Treg) subsets return in patients with refractory lupus following stem cell transplantation, and TGF-beta-producing CD8+ Treg cells are associated with immunological remission of lupus.
Zhang L; Bertucci AM; Ramsey-Goldman R; Burt RK; Datta SK
J Immunol; 2009 Nov; 183(10):6346-58. PubMed ID: 19841178
[TBL] [Abstract][Full Text] [Related]
20. Nasal anti-CD3 antibody ameliorates lupus by inducing an IL-10-secreting CD4+ CD25- LAP+ regulatory T cell and is associated with down-regulation of IL-17+ CD4+ ICOS+ CXCR5+ follicular helper T cells.
Wu HY; Quintana FJ; Weiner HL
J Immunol; 2008 Nov; 181(9):6038-50. PubMed ID: 18941193
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
